Factor V Deficiency with a Thrombotic Clinical Phenotype

Meera Sridharan; Lea M. Coon; Dong Chen; Rajiv K. Pruthi

doi:10.1055/s-0038-1677041

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2019; 45(01): 108-112
DOI: 10.1055/s-0038-1677041

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Factor V Deficiency with a Thrombotic Clinical Phenotype

Meera Sridharan

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota

²Division of Hematopathology and Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota

,

Lea M. Coon

²Division of Hematopathology and Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota

,

Dong Chen

²Division of Hematopathology and Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota

,

Rajiv K. Pruthi

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota

²Division of Hematopathology and Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota

References
1 Duga S, Asselta R, Tenchini ML. Coagulation factor V. Int J Biochem Cell Biol 2004; 36 (08) 1393-1399
2 Dahlbäck B. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S. J Thromb Haemost 2017; 15 (07) 1241-1250
3 Dahlbäck B. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders. Int J Lab Hematol 2016; 38 (Suppl. 01) 4-11
4 Duckers C, Simioni P, Rosing J, Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol 2009; 146 (01) 17-26
5 Lunghi B, Scanavini D, Castoldi E. , et al. The factor V Glu1608Lys mutation is recurrent in familial thrombophilia. J Thromb Haemost 2005; 3 (09) 2032-2038
6 Norstrøm E, Thorelli E, Dahlbäck B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002; 100 (02) 524-530
7 Zehnder JL, Jain M. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. Blood Coagul Fibrinolysis 1996; 7 (03) 361-362
8 Simioni P, Castoldi E, Lunghi B, Tormene D, Rosing J, Bernardi F. An underestimated combination of opposites resulting in enhanced thrombotic tendency. Blood 2005; 106 (07) 2363-2365
9 Middleton R, Gao D, Thomas A. , et al. IRFinder: assessing the impact of intron retention on mammalian gene expression. Genome Biol 2017; 18 (01) 51
10 Lek M, Karczewski KJ, Minikel EV. , et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536 (7616): 285-291
11 Macedo-Ribeiro S, Bode W, Huber R. , et al. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 1999; 402 (6760): 434-439
12 Dennis J, Johnson CY, Adediran AS. , et al. The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. Blood 2012; 119 (10) 2392-2400
13 Medina P, Navarro S, Estellés A, Vayá A, Bertina RM, España F. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thromb Haemost 2005; 94 (02) 389-394
14 Nishiya K, Kikukawa Y, Shinozawa K, Yada H, Fukutake K, Shima M. Deep venous thromboembolism in a patient of factor V deficiency. Paper presented at the 22nd Congress of the International Society of Thrombosis and Haemostasis. Boston, MA: 2009
15 Janicki PK, Vaida S, Al-Mondhiry HA. Targeted next-generation resequencing of f5 gene identifies novel multiple variants pattern in severe hereditary factor v deficiency. Case Rep Genet 2013; 2013: 941684
16 Reich NE, Hoffman GC, deWolfe VG, Van Ordstrand HS. Recurrent thrombophlebitis and pulmonary emboli in congenital factor 5 deficiency. Chest 1976; 69 (01) 113-114
17 Manotti C, Quintavalla R, Pini M, Jeran M, Paolicelli M, Dettori AG. Thromboembolic manifestations and congenital factor V deficiency: a family study. Haemostasis 1989; 19 (06) 331-334
18 Miller SP. Coagulation dynamics in factor V deficiency: a family study, with a note on the occurrence of thrombophlebitis. Thromb Diath Haemorrh 1965; 13: 500-515
19 García-Noblejas A, Osorio S, Durán AI. , et al. Pulmonary embolism in a patient with severe congenital deficiency for factor V during treatment with fresh frozen plasma. Haemophilia 2005; 11 (03) 276-279
20 Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost 2013; 39 (06) 684-692
21 Duckers C, Simioni P, Spiezia L. , et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood 2010; 115 (04) 879-886